article thumbnail

STAT+: FTC warns drugmakers they can face legal action over improper patent listings

STAT

The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly list patents for brand-name medicines in a Food and Drug Administration registry, the latest effort by the federal government to scrutinize patent moves by drugmakers. Continue to STAT+ to read the full story…

article thumbnail

STAT+: Contributors to psychiatry’s bible, the DSM-5, got $14 million from industry

STAT

And the authors argue the findings raise questions about the editorial independence of the reference book. The researchers found that, of the 55 physicians with ties to a pharmaceutical company, 91% accepted food and beverages, and 69% received compensation for travel and consulting, according to the analysis published in the BMJ.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Applied Virtual Reality in Healthcare: A comprehensive book on medical XR

pharmaphorum

Our book Applied Virtual Reality in Healthcare provides an overview of innovative approaches, best practices, and coherent solutions to common concerns. The book notes pharma can utilise VR for clinical trials as it allows for a better understanding of the research subject. To learn more about the IVRHA conference, click here.

article thumbnail

Episode 15 – Book Discussion with J P Pathak | Humans of Pharma

PharmaState Academy

Episode 15 - Book Discussion with J P Pathak | Humans of Pharma In Episode 15 of our book discussion series, we will discuss the book of Mr. J P Pathak Title: The One Thing- That Will Make You an Effective Leader About the author: J P Pathak He is a seasoned professional with an illustrious career spanning over three decades in the pharma industry.

article thumbnail

The Issue with Reissue: PTE Edition

FDA Law Blog: Biosimilars

Specifically, the Court focused on the purpose: to compensate pharmaceutical companies for the effective truncation of their patent terms while waiting for regulatory approval of new drug applications. The question is important because the result of that determination could drastically reduce the amount of patent term to be restored.

article thumbnail

4 ways to embed data-driven best practice in pharma HCP communications

pharmaphorum

A new e-book from Veeva recommends four key steps that can help a pharma organisation become a data-driven company: Ensure data is owned by data experts. The e-book explores each of these foundational steps in depth and gives advice for pharma companies on how to implement them. Require data-driven decision making.

article thumbnail

Patient centricity is becoming business critical for pharma

pharmaphorum

New book sets the pharmaceutical industry on a course for bridging the patient centricity optimism gap. That’s according to Sharon Suchotliff, patient centricity lead at consultancy firm ZS Associates, which has just published a book on the art of patient involvement. Patient centricity is not a new conversation in pharma.